Chengda Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 25.2% in First Quarter of 2023

Chengda Pharmaceuticals Co.,Ltd. (诚达药业股份有限公司) (301201.SZ) reported a net profit of 19.6 million yuan in the first quarter of 2023, down 25.2% year-on-year.

Meanwhile, the company posted 102.2 million yuan in revenue, down 5.9% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 120 million yuan in total liabilities, with a liability-to-asset ratio of 5.1%.